Glucagon‐Like Peptide‐1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin‐Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies

Jerry R. Greenfield, Ruth Frampton, Jennifer R. Snaith
Diabetes, Obesity and Metabolism · Wiley · 2026-11-04 · DOI: 10.1111/dom.71505

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles